| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.03 |